Abstract
Ribonuclease H2 plays an essential role for genome stability as it removes ribonucleotides misincorporated into genomic DNA by replicative polymerases and resolves RNA/DNA hybrids. Hypomorphic loss-of-function mutations in the genes encoding the three RNase H2 subunits cause the type I interferonopathies Aicardi-Goutières syndrome (AGS) and systemic lypus erythe-motosus (SLE). We showed that in patients with AGS and SLE mutations cause enhanced levels of ribonucleo-tides in genomic DNA. We analyzed the proteomic environment of the RNase H2 complex and identified RNase Inhibitor 1 (RNH1) as an interactor. We validated the interaction of RNH1 with RNase H2 on an endogenous level using co-immunoprecipitation. Furthermore, we demonstrated that a siRNA-induced knockdown of RNH1 in HeLa cells causes low level DNA damage, activation of p53 and up-regulation of type I interferon-stimulated genes. These findings suggest a role of RNH1 in the regulation of RNase H2 function and implicate RNH1 in AGS pathogenesis.
Cite
CITATION STYLE
Kind, B., Schmidt, F., Kretschmer, S., Shevchenko, A., & Lee-Kirsch, M. (2015). Role of RNH1 in the regulation of RNase H2 function. Pediatric Rheumatology, 13(S1). https://doi.org/10.1186/1546-0096-13-s1-o3
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.